Ozempic and Mounjaro drug makers are facing a lawsuit from a woman who says she had stomach paralysis as a side effect from the Type 2 diabetes drugs.

FDA erteilt De-Novo-Zulassung für das Spur® Peripheral Retrievable Stent System von Reflow Medical ...

Il sagit d’une solution clinique unique pour le traitement des lésions De Novo ou resténotiques après prédilatation chez les patients atteints d'une maladie artérielle infrapoplitée.

Home | News & events | Australians join elite group of scientists using AI to create man-made proteins Australians join elite group of scientists using AI to create man-made proteins 10 July 2025 ...

Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its blockbuster semaglutide (GLP-1 RA)-based therapies, Wegovy for obesity and ...

Amgen recently released the full data from a trial involving its GLP-1 drug, MariTide. More than one-quarter of the participants on the highest dosage of the drug had to stop taking it due to ...

More than 1.3 million people have been displaced in Haiti as surging gang violence, lawlessness, and impunity expose the population – especially women and girls – to heightened risks of exploitation ...

If you're looking for a top healthcare stock to buy that has much more upside in GLP-1, then going with Eli Lilly or Novo Nordisk can make much more sense at this stage.

Jared Holz, Mizuho Securities health care strategist, joins CNBC's 'Squawk on the Street' to discuss weight loss drug makers, how CVS is boosting access to Wegovy, and more.